In the first part of the study, the modified expression of these miRNAs in two classifications of muscular dystrophy was examined, the initial one retaining an intact expression of the dystrophin-linked glycoprotein complex (DAPC) (DMD, SGCA, and SGCG) and second category involving the compromised structural integrity of the DAPC (CAPN3, DYSF, healthy controls). This evidence concerns the gene SGCG and muscular dystrophy.